Skip to content

Hair Benefit Study For The Ayurvedic Proprietary Medicine

A clinical study to evaluate the efficacy of the test products in improving hair growth & hair fall reduction.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/053922
Enrollment
225
Registered
2023-06-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Hindustan Unilever Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male and female volunteers in general good health with mild to moderate hair fall 2. Volunteers in the age group 18-50 years (both the ages inclusive). 3. Volunteers willing to give a written informed consent and agree to come for a regular follow up visit. 4. Volunteers willing to abide by and comply with the study protocol. 5. Volunteers who have not participated in a similar investigation in the past three months. 6. Volunteers with no known allergy as established by medical history. 7. Volunteers who do not smoke or drink alcohol. 8. Volunteers who are not crash dieting. 9. Volunteers who agree to refrain from using hair dye / hair colour during the study period. 10. Volunteers willing to refrain from any type of hair treatment like perming, straightening etc. during the study duration. 11. Volunteers who are willing to refrain from any other oil treatment/hair spa and oral medications for hair growth during the study.

Exclusion criteria

Exclusion criteria: 1. Volunteers who have undergone hair growth treatment within 3 months before screening into the study. 2. Volunteers having any active scalp disease which may interfere in the study dermatologist’s judgement. 3. Volunteers who have taken chemotherapy for cancer in the 6 months prior to start of the study or have a plan to do treatments during study. 4. Volunteers who have history of alcoholism and/ or psychiatric disorder including trichotillomania. 5. Volunteers who have had hair transplants. 6. Volunteers who take pharmaceutical product which cause hirsutism (ex. phenytoin) and finesteride for androgenic alopecia. 7. A known history or present condition of allergic response/hypersensitivity to any cosmetic ingredients and pharmaceutical products. 8. Volunteers consuming alcohol and smoking 9. Volunteers on oral medications which will compromise the study. 10. Volunteers who are pregnant or lactating or nursing as established with medical history. 11. Volunteers under any medical treatment for hair problems 12. Undergoing any chemical hair salon treatment-straightening / perming / colour 13. Menopausal female volunteers as determined by medical history. 14. Pregnant and lactating female volunteers 15. Chronic illness which may influence the cutaneous state. Volunteers participating in other similar cosmetic or therapeutic trial within last three months. 16. Any history of underlying uncontrolled medical illness including diabetes mellitus, hypertension, HIV, hepatitis, severe anemia, serious disorder of heart and respiratory apparatus or any other serious medical illness.

Design outcomes

Primary

MeasureTime frame
1. Significant improvement in hair growth, reduction in hair fall 2. Significant reduction in Kesh chyuti or kalitya (hair fall)Timepoint: 4, 8, 12 weeks

Secondary

MeasureTime frame
Significant improvement in hair fibre thicknessTimepoint: 4, 8, 12 weeks

Countries

India

Contacts

Public ContactSudhanthiran S

MS Clinical Research Pvt Ltd

arya.p@msclinical.com08041125934

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026